Approved Tyrosine Kinase Inhibitor for Metastatic Mast Cell TumorAUSTIN, Texas--(BUSINESS WIRE)--#animalhealth--VMD Sciences, the leader in global veterinary pharmaceutical access services, announced ...
AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, LLC, a pioneering company dedicated to accelerating biomedical innovation for pets, veterinarians, and pet owners, today announces the launch of its ...
AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, the global leader in veterinary regulatory pharmaceutical services, played a pivotal role in helping a community veterinarian access an experimental ...
A C-17 Globemaster III assigned to the 701st Airlift Squadron, Joint Base Charleston, S.C., taxis out during Exercise Patriot Sands, Homestead Air Reserve Base, Fla., Feb. 23, 2019. (U.S. Air Force ...
The acquisition, completed in partnership with institutional capital, adds to a series of high-performing strategic transactions by the firm across Massachusetts. Over the past two years, VMD has ...
VIEMED HEALTHCARE ($VMD) posted quarterly earnings results on Monday, March 10th. The company reported earnings of $0.10 per share, missing estimates of $0.11 by $0. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results